Wu WK - Search Results

1

Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer.

Yu J, Ma X, Cheung KF, Li X, Tian L, Wang S, Wu CW, Wu WK, He M, Wang M, Ng SS, Sung JJ. Yu J, et al. Among authors: wu cw, wu wk. Oncogene. 2010 Dec 9;29(49):6464-74. doi: 10.1038/onc.2010.370. Epub 2010 Aug 30. Oncogene. 2010. PMID: 20802524

2

Bone morphogenetic protein signalling is required for the anti-mitogenic effect of the proteasome inhibitor MG-132 on colon cancer cells.

Wu WK, Sung JJ, Wu YC, Li ZJ, Yu L, Cho CH. Wu WK, et al. Among authors: wu yc. Br J Pharmacol. 2008 Jun;154(3):632-8. doi: 10.1038/bjp.2008.115. Epub 2008 Apr 14. Br J Pharmacol. 2008. PMID: 18414391 Free PMC article.

3

MicroRNA dysregulation in gastric cancer: a new player enters the game.

Wu WK, Lee CW, Cho CH, Fan D, Wu K, Yu J, Sung JJ. Wu WK, et al. Among authors: wu k. Oncogene. 2010 Oct 28;29(43):5761-71. doi: 10.1038/onc.2010.352. Epub 2010 Aug 30. Oncogene. 2010. PMID: 20802530 Review.

4

MicroRNA dysregulation in colorectal cancer: a clinical perspective.

Dong Y, Wu WK, Wu CW, Sung JJ, Yu J, Ng SS. Dong Y, et al. Among authors: wu wk, wu cw. Br J Cancer. 2011 Mar 15;104(6):893-8. doi: 10.1038/bjc.2011.57. Epub 2011 Mar 1. Br J Cancer. 2011. PMID: 21364594 Free PMC article. Review.

5

The autophagic paradox in cancer therapy.

Wu WK, Coffelt SB, Cho CH, Wang XJ, Lee CW, Chan FK, Yu J, Sung JJ. Wu WK, et al. Oncogene. 2012 Feb 23;31(8):939-53. doi: 10.1038/onc.2011.295. Epub 2011 Jul 18. Oncogene. 2012. PMID: 21765470 Review.

6

Intrarectal administration of mCRAMP-encoding plasmid reverses exacerbated colitis in Cnlp(-/-) mice.

Tai EK, Wu WK, Wang XJ, Wong HP, Yu L, Li ZJ, Lee CW, Wong CC, Yu J, Sung JJ, Gallo RL, Cho CH. Tai EK, et al. Among authors: wu wk. Gene Ther. 2013 Feb;20(2):187-93. doi: 10.1038/gt.2012.22. Epub 2012 Mar 1. Gene Ther. 2013. PMID: 22378344

7

Cathelicidin protects against Helicobacter pylori colonization and the associated gastritis in mice.

Zhang L, Yu J, Wong CC, Ling TK, Li ZJ, Chan KM, Ren SX, Shen J, Chan RL, Lee CC, Li MS, Cheng AS, To KF, Gallo RL, Sung JJ, Wu WK, Cho CH. Zhang L, et al. Among authors: wu wk. Gene Ther. 2013 Jul;20(7):751-60. doi: 10.1038/gt.2012.92. Epub 2012 Dec 20. Gene Ther. 2013. PMID: 23254369

8

The Janus face of cathelicidin in tumorigenesis.

Wu WK, Sung JJ, Cheng AS, Chan FK, Ng SS, To KF, Wang XJ, Zhang L, Wong SH, Yu J, Cho CH. Wu WK, et al. Curr Med Chem. 2014;21(21):2392-400. doi: 10.2174/0929867321666140205135351. Curr Med Chem. 2014. PMID: 24524763 Review.

9

Disruption of NCOA2 by recurrent fusion with LACTB2 in colorectal cancer.

Yu J, Wu WK, Liang Q, Zhang N, He J, Li X, Zhang X, Xu L, Chan MT, Ng SS, Sung JJ. Yu J, et al. Among authors: wu wk. Oncogene. 2016 Jan 14;35(2):187-95. doi: 10.1038/onc.2015.72. Epub 2015 Mar 30. Oncogene. 2016. PMID: 25823027 Free PMC article.

10

The role of cathelicidin in control of Helicobacter pylori colonisation in the stomach.

Cho CH, Yu J, Zhang L, Wu WK. Cho CH, et al. Among authors: wu wk. Hong Kong Med J. 2015 Jun;21 Suppl 4:17-9. Hong Kong Med J. 2015. PMID: 26157097 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

599 results

Search Page

Filters